Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents

Author:

Alexander Paul E.,Armstrong Robin,Fareed George,Lotus John,Oskoui Ramin,Prodromos Chad,Risch Harvey A.,Tenenbaum Howard C.,Wax Craig M.,Dara Parvez,McCullough Peter A.,Gill Kulvinder K.

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. American Geriatrics Society. American Geriatrics Society Policy Brief: COVID-19 and Nursing Homes. J Am Geriatr Soc. 2020 May;68(5):908-91doi: 10.1111/jgs.16477. Epub 2020 Apr 29. PMID: 32267538; PMCID: PMC7262210.

2. Centers for Disease Control and Prevention (CDC). People who are at higher risk for severe illness.url: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html. (Accessed on December 25th 2020).

3. Bernabeu-Wittel M, Ternero-Vega JE, Nieto-Martín MD, Moreno-Gaviño L, Conde-Guzmán C, Delgado-Cuesta J, Rincón-Gómez M, Díaz-Jiménez P, Giménez-Miranda L, Lomas-Cabezas JM, Muñoz-García MM, Calzón-Fernández S, Ollero-Baturone M. Effectiveness of an On-Site Medicalization Program for Nursing Homes with COVID-19 Outbreaks. J Gerontol A Biol Sci Med Sci. 2020 Aug 1:glaa192. doi: 10.1093/gerona/glaa192. Epub ahead of print. PMID: 32738140; PMCID: PMC7454360.

4. Heras E, Garibaldi P, Boix M, Valero O, Castillo J, Curbelo Y, Gonzalez E, Mendoza O, Anglada M, Miralles JC, Llull P, Llovera R, Piqué JM. COVID-19 mortality risk factors in older people in a long-term care center. Eur Geriatr Med. 2020 Nov 27:1–7. doi: 10.1007/s41999-020-00432-w. Epub ahead of print. PMID: 33245505; PMCID: PMC7693854.

5. De Spiegeleer A, Bronselaer A, Teo JT, Byttebier G, De Tré G, Belmans L, Dobson R, Wynendaele E, Van De Wiele C, Vandaele F, Van Dijck D, Bean D, Fedson D, De Spiegeleer B. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. J Am Med Dir Assoc. 2020 Jul;21(7):909–14.e2. doi: 10.1016/j.jamda.2020.06.018. Epub 2020 Jun 1PMID: 32674818; PMCID: PMC7294267.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3